Is It Time To Sell Serco Group plc?

Serco Group plc (LON: SRP) is sliding again today as cash call concerns circle the company.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Troubled outsourcing company Serco Group (LSE: SRP) is in the news once again today, as uncertainty surrounds the troubled group’s cash call, which was announced at the end of last week. 

In particular, Serco pre-announced last week that it intends to launch a fully underwritten £550m equity issue in March, when it completes a strategic review. However, investors have become concerned about the level of dilution now required to achieve this level of funding. 

Indeed, Serco’s shares have slumped by around 40%, to a ten-year low, since the rights issue was announced. This implies that the company will have to issue more shares than it originally intended, in order to achieve the level of funding required. 

And there’s little chance that the size of the rights issue will be scaled back. After announcing £1.5bn of impairment charges alongside the rights issue last week, Serco’s balance sheet is in need of a sudden cash infusion. So the company needs a hefty cash infusion to shore up its creaking balance sheet.

Plenty of uncertainty

It’s not just the potential dilution that’s concerning investors. There are now plenty of question marks hanging over Serco’s ability to compete effectively in the global market place. 

Over the past month, problems have continued to emerge with the group’s handling of contracts awarded to it over the past few years. These problems include a deal to accommodate asylum seekers, running healthcare services in Suffolk and maintaining the Royal Maritime Auxiliary fleet.

As the company struggles, City analysts believe that Serco’s free cash flow will be negative during 2014 and 2015; bad news for a company that’s already running out of cash. 

What’s more, City analysts believe that at the current share price, in order for Serco to raise enough cash to bolster its balance sheet, the potential dilution will reduce 2016 earnings per share to only 6p. 

In other words, according to current City forecasts, at present levels Serco is currently trading at a 2016 P/E of 27.2. This is an exceptionally high multiple for a company that struggling to turn itself around. 

Nevertheless, these figures are only estimates. It’s still not clear how many rights Serco will have to issue to raise all the cash it needs. 

Slimming down 

Despite the uncertainty surrounding Serco’s future, the company is trying to change its image: the group has brought on a new CEO, Rupert Soames, and chairman Alastair Lyons — who has been chairman of the company since 2010 — resigned earlier this week.

Further, Serco plans to sell off a host of businesses and it is hoped that a good business will emerge from the ashes when the turnaround is complete.

Still, there’s no denying that Serco has plenty of work to do before its recovery is complete and for the time being, I would sit on the sidelines. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

UK stocks are 52% discounted, says Goldman Sachs

With UK stocks staggeringly cheap right now, this Fool took the chance to add one unloved FTSE 100 share to…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Up 107% in 2024, can this FTSE 250 star keep soaring?

Christopher Ruane looks at a FTSE 250 share that has more than doubled in price so far in 2024 and…

Read more »

Investing Articles

Could 2025 be a great year for the stock market?

2024 has been a record-breaking year in the stock market on both sides of the pond. Our writer explains the…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

An investor buying £10,000 of IAG shares at the start of 2024 would now have this much!

Anyone who had the courage to buy IAG shares at the beginning of the year will be sitting pretty right…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Might Netflix snap up this household name from the FTSE 250?

The ITV share price has been rising over the past few weeks due to takeover speculation. Should I buy this…

Read more »

Growth Shares

2 value shares with notably low P/B ratios

Jon Smith points out some potential value shares that have price-to-book (P/B) ratios below one at the moment.

Read more »

Investing Articles

Top FTSE 100 shares poised to benefit from artificial intelligence in 2025

While US investors are tripping over themselves to grab the latest AI stocks, our writer looks for opportunities closer to…

Read more »

US Stock

This S&P 500 stock could rise 57% in 2025, according to Goldman Sachs

Shares in this well-known S&P 500 tech company can currently be snapped up for $61. Analysts at Goldman Sachs reckon…

Read more »